Articles by Patricia Van Arnum - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Patricia Van Arnum

Applying Catalysis to Optimize API Synthesis

Fine-chemical companies, contract manufacturers, and researchers advance chemocatalysis and biocatalysis.
Nov 2, 2013

Fine-chemical companies, contract manufacturers, and researchers advance chemocatalysis and biocatalysis.

AstraZeneca Received Mixed Decision on US Patent Litigation

Nov 1, 2013

A US court of appeals rules on patent litigation for AstraZeneca's asthma drug Pulmicort Respules (budesonide).

A Strong Outlook for Global Pharma Outsourcing

Oct 23, 2013

Overall growth in the market for pharmaceutical contract research and manufacturing is strong although growth in established markets erodes at the expense of emerging markets.

Quality by Design in APIs

The adoption of quality by design in small-molecule drug development and manufacturing continues to evolve as the industry seeks ways to augment process understanding for APIs
Oct 23, 2013

The adoption of quality by design in small-molecule drug development and manufacturing continues to evolve as the industry seeks ways to augment process understanding for APIs.

Evaluating Strategies for Oral Absorption Enhancement

Formulation scientists tackle the challenges of improving drug absorption across the gastrointestinal membrane.
Oct 23, 2013

Formulation scientists tackle the challenges of improving drug absorption across the gastrointestinal membrane.

Cambridge Major Laboratories Discusses Strategy on its Merger with AAIPharma Services

Oct 22, 2013

Brian Scanlan, CEO and president of Cambridge Major Laboratories, discusses the rationale behind the company's merger with AAIPharma Services.

Tracking Biologics Manufacturing Investment by Big Pharma

Oct 17, 2013

Roche's plans for a major biologics manufacturing expansion is the latest investment by Big Pharma

Pharma Companies and CMOs Invest in ADC Technology

Oct 17, 2013

AstraZeneca and SAFC are the latest companies to expand positions in antibody drug conjugates (ADCs).

Tracking Biotech Financing

Global biotechnology financing through the first nine months of 2013 shows that initial public offerings are on the rise while venture-capital funding stays relatively flat.
Oct 9, 2013

Global biotechnology financing through the first nine months of 2013 shows that initial public offerings are on the rise while venture-capital funding stays relatively flat.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here